Surgical robotics systems and devices having a sterile restart, and methods thereof

Information

  • Patent Grant
  • 12089908
  • Patent Number
    12,089,908
  • Date Filed
    Tuesday, November 7, 2023
    a year ago
  • Date Issued
    Tuesday, September 17, 2024
    4 months ago
Abstract
The present disclosure relates to surgical robotic systems having a master console and slave manipulators, with components and features for enabling a restart without comprising the sterility of the surgical robotic system. In some embodiments, an apparatus can include a restart of a surgical robotic system that is configured to be activated by a sterile user from within a sterile field without compromising the sterile field, and a controller operatively coupled to the restart that is configured to detect that the restart has been activated and, in response to detecting that the restart has been activated, restart the surgical robotic system.
Description
TECHNICAL FIELD

This application generally relates to surgical robot systems, and specifically to systems, devices, and methods for restarting a surgical robotic system without comprising sterility.


BACKGROUND

In robotically-assisted or tele-manipulated surgical robotic systems, a surgeon operates a master console to remotely control one or more slave devices or surgical instruments at a surgical site. During the operation of the surgical robotic system, there may be events or factors that cause unexpected movement and/or operation of one or more components of the system. In these instances, a surgical robotic system may transition into a safe operating mode, whereby one or more functions of the surgical robotic system may be disabled. To restart the surgical robotic device, a surgeon or other user within an operating room may need to perform one or more actions that may compromise a sterile field. In some cases, the surgeon or other user may also need to release one or more surgical instruments from a patient before initiating a restart. If the sterile field is compromised either during an instrument release or restart of the surgical robotic system, then significant delays may result in a surgical procedure. As such, it may be desirable to have a way to restart a surgical robotic system without comprising the sterile field.


BRIEF DESCRIPTION

The present disclosure overcomes the drawbacks of previously-known surgical robotic systems by providing systems, devices, and methods for restarting a surgical robotic system without comprising sterility of a surgical site.


In some embodiments, an apparatus can include: a restart of a surgical robotic system that is configured to be activated by a sterile user from within a sterile field without compromising the sterile field; and a controller operatively coupled to the restart, the controller configured to: detect that the restart has been activated; and in response to detecting that the restart has been activated, restart the surgical robotic system.


In some embodiments, an apparatus can include: a restart of a surgical robotic system that is configured to be activated by a user from within a sterile field without compromising the sterile field; and a controller operatively coupled to the restart, the controller configured to: detect that the restart has been activated; in response to detecting that the restart has been activated, determine whether an instrument is coupled to a slave manipulator of the surgical robotic system; and in response to determining that the instrument is in the active state, enabling telemanipulation of the instrument in a predefined set of degrees-of-freedom (DOFs) that allows the instrument to engage further with or disengage from tissue or other components within a body of a patient without compromising the sterile field.


In some embodiments, a system can include: at least one slave manipulator isolated from a sterile field by a first sterile barrier, the at least one slave manipulator including a plurality of slave links and a plurality of drive units; at least one instrument configured to be removably coupled to the at least one slave manipulator, the at least one sterile instrument configured to be positioned via movement of the plurality of slave links and to be manipulated in a plurality of degrees-of-freedom (DOFs) via activation of the plurality of drive units; and a master console disposed separately from the slave manipulator and isolated from the sterile field by a second sterile barrier, the master console including a plurality of master links being operatively coupled to the plurality of slave links such that movement of the plurality of master links causes corresponding movement in the plurality of slave links; at least one sterile handle grip configured to be removably coupled to the master console, the at least one sterile handle grip when coupled to the master console being configured to control the activation of the plurality of drive units to manipulate the at least one instrument in the plurality of DOFs; a restart that is configured to be activated by a user from within the sterile field without compromising the sterile field; and at least one controller operatively coupled to the at least one slave manipulator and the master console, the controller configured to: deactivate controlled movement of the plurality of slave links and the manipulation of at least one instrument during a surgical procedure in response to detecting an abnormal event; detect that the restart has been activated; and after detecting that the restart has been activated, restart the surgical robotic system.


In some embodiments, a method for maintaining sterility of a surgical robotic system while restarting during a surgical procedure can include: after the interruption and with a slave manipulator of the surgical robotic system being deactivated from movement, detecting that a restart of the surgical robotic system that is configured to be activated from within a sterile field and without compromising sterility has been activated; and after detecting that the restart has been activated, restarting the surgical robotic system.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 schematically depicts a surgical robotic system, according to embodiments.



FIG. 2 schematically depicts a surgical robotic system in an environment around a sterile area, according to embodiments.



FIG. 3 shows an example surgical robotic system including a master console and multiple slave manipulators, according to embodiments.



FIG. 4 depicts the sterile zones around the example surgical robotic system of FIG. 3, according to embodiments.



FIG. 5 depicts a detailed view of an instrument coupling of a surgical robotic system, according to embodiments.



FIG. 6 depicts the sterile boundary around the instrument coupling of a surgical robotic system, according to embodiments.



FIG. 7 depicts an emergency release tool for releasing an instrument of a surgical robotic system, according to embodiments.



FIG. 8 depicts a power supply switch of a slave manipulator of a surgical robotic system, according to embodiments.



FIG. 9 depicts the sterile and non-sterile zones around a master console of a surgical robotic system, according to embodiments.



FIG. 10 depicts an example restart of a surgical robotic system, according to embodiments.



FIGS. 11 and 12 are flow charts of an example method for restarting a surgical robotic system with an instrument release, according to embodiments.



FIG. 13 is a flow chart of an example method for restarting a surgical robotic system, according to embodiments.





DETAILED DESCRIPTION

The present disclosure relates to surgical robotic systems having a master console and slave manipulators, with components and features for enabling a restart without comprising the sterility of the surgical robotic system. Systems, devices, and methods described herein allow a surgical robotic system to be restarted as well as an instrument to be released (or to perform other functions) after a temporary interruption, while maintaining a sterile environment.


During a surgical operation, a surgical robotic system may be used to perform certain minimally invasive procedures. In some embodiments, the surgical robotic system may include one or more patient-side carts and a surgeon or master console. The patient-side carts may include manipulators (e.g., robotic arms) that support one or more sterile instruments, which may be used during the surgical operation to engage with the patient anatomy. At times, it may become necessary to restart the surgical robotic system. For example, the surgical robotic system may experience a temporary interruption if certain events and/or conditions arise (e.g., unexpected movement, collisions, component failure). When there is a temporary interruption, the surgical robotic system may disable certain functions (e.g., deactivate movement of the slave manipulators and/or sterile instruments). To then resume the surgical robotic operation, the surgical robotic system may need to be restarted and/or any instruments coupled to the surgical robotic system may need to be released from the patient anatomy.



FIG. 1 schematically depicts a surgical robotic system 100, according to embodiments. The system 100 can include a master console 110 and one or more slave console(s) 120. Optionally, the system 100 can also include an imaging device 130, such as, for example, an endoscopic camera.


The master console 110 can be operatively coupled to the slave console(s) 120. For example, the master console 110 can be coupled to the slave console(s) 120 via wired and/or wireless connections. The master console 110 can include one or more master manipulator(s) 112 and one or more master controller(s) 114. The master manipulator(s) 112 can include a plurality of master links that are interconnected by a plurality of joints. Movement can be applied to the master manipulator(s) 112 by a sterile handle, which can be actuated by a sterile user (e.g., a surgeon). The movement of the master manipulator(s) 112 and one or more actuators of the handle can be sensed, e.g., using a plurality of sensors, and transmitted to the master controller(s) 114. In operation, the master controller(s) 114 can send instructions to one or more slave console(s) 120 to cause one or more drive units and/or actuators at the slave console(s) 120 to move based on the movements applied at the master console 110.


Each slave console 120 can include a slave manipulator 122 and/or an instrument 128 that is coupled to the slave manipulator 122. The slave manipulator 122 can include a plurality of links that are interconnected by a plurality of joints, and the instrument 128 can include one or more components that can be actuated in a plurality of degrees of freedom (DOFs). The slave console(s) 120 can include one or more drive units and/or actuators that control movement of the plurality of links and joints of the slave manipulator 122 and the component(s) of the instrument 128. In accordance with aspects of the present disclosures, the slave manipulator 112 and the instrument 128 of the slave console(s) 120 can be configured to move in a manner responsive to movements applied at the handle of the master console 110, such that the slave manipulator 112 and the instrument 128 reproduces the movement applied at the handle of the master console 110. In particular, the master console 110 can generate instructions or commands based on movements applied at the handle and transmit those instructions or commands to the slave console(s) 120 to cause movement of the slave manipulator 112 and/or the instrument 128. The slave console(s) 120 can include a slave controller 124 that can be configured to interpret the instructions or other signals from the master console 110 and to control the movement of the slave manipulator 112 and/or the instrument 128.


While the slave console 120 is described as having a slave manipulator 122 and an instrument 128, it can be appreciated that a single slave console 120 can include more than one slave manipulator 122 and/or more than one instrument 128. For example, a slave console 120 can include two slave manipulators 122 that each support one or more instruments 128.


The master controller(s) 114 and the slave controller(s) 124, as described herein, can include one or more of a memory, a processor, a communications interface, and/or an input/output device. The memory can include any type of suitable non-transitory compute readable media that can store instructions that can be executed by one or more processors. The memory can be, for example, a random access memory (RAM), a memory buffer, a hard drive, a database, an erasable programmable read-only memory (EPROM), an electrically erasable read-only memory (EEPROM), a read-only memory (ROM), and/or so forth. The processor can be any suitable processing device configured to run and/or execute functions associated with the surgical robotic system 100. The processor can be a general purpose processor, a Field Programmable Gate Array (FPGA), an Application Specific Integrated Circuit (ASIC), a Digital Signal Processor (DSP), and/or the like. The communications interface can include wired and/or wireless interfaces for receiving information and/or sending information to other devices. The input/output device can include one or more displays, audio devices, touchscreens, keyboards, or other input or output devices for presenting information to and/or receiving information from a user.


Further examples of surgical robotic systems are described in PCT Patent Application No. PCT/IB2020/050039, filed Jan. 4, 2020, titled “Surgical Robot Systems Comprising Robotic Telemanipulators and Integrated Laparoscopy,” and U.S. patent application Ser. No. 16/269,383, filed Feb. 6, 2019, titled “Surgical Robot Systems Comprising Robotic Telemanipulators and Integrated Laparoscopy,” the disclosures of each of which are incorporated by reference herein.



FIG. 2 depicts the master console 110, the slave console(s) 120, and the imaging device 130 in an operating room 104, including a sterile area 103, according to embodiments. The master console 110, the slave console(s) 120, and the imaging device 130 can be designed to remain sterile during a surgical operation.


As depicted, the master console 110 can be located within the operating room 104. The master console 110 can include a portion that covered by one or more sterile drape(s) 111, which allows that portion of the master console 110 to remain sterile during a surgical operation. In some embodiments, the master manipulator(s) 112 and the master controller(s) 114 can be covered by one or more sterile drape(s) 111, while certain sterile components (e.g., handles) can be removably coupled to the master manipulator at sterile coupling interfaces.


The slave console(s) 120 can be located within the operating room 104 and distributed around a patient P. Each slave console 120 can include a portion that is covered by one or more sterile drapes 121, which allows that portion of the respective slave console 120 to remain sterile during the surgical operation. The slave console(s) 120 can be configured to support and manipulate one or more surgical instruments. The surgical instruments can be sterile, and can be removably coupled to the slave console(s) 120 via sterile coupling interfaces.


If the system 100 includes an imaging device 130, then the imaging device 130 can also include a portion that is covered by one or more sterile drapes 131, which allows that portion of the imaging device 130 to remain sterile during a surgical operation.


While one or more controllers are described with reference to FIGS. 1 and 2, it can be appreciated that any functions implemented by one controller can be implemented by one or more controllers, and that the recitation of “a controller” is not limited to that of a single controller but can encompass one or more controllers.



FIG. 3 depicts an example of a surgical robotic system 200, according to embodiments. The surgical robotic system 200 can be structurally and/or functionally similar to other surgical robotic systems described herein, including, for example, the surgical robotic system 100, and therefore can include components that are structurally and/or functionally similar to the components of such other systems. For example, the surgical robotic system 200 can include a master console 210 including two master manipulators 212a and 212b (e.g., left and right manipulators) and a master controller 214, two slave consoles 220a, 220b (e.g., left and right slave consoles), and an imaging device implemented as an endoscope device 230.


In operation, movement of the first slave manipulator 212a (and handle coupled thereto) can be sensed and transmitted to the master controller 214, which can then send instructions to a first slave console 220a to control the movement of the first slave console 220a. Similarly, movement of the second slave manipulator 212b (and handle coupled thereto) can be sensed and transmitted to the master controller 214, which can then send instructions to a second slave console 220b to control the movement of the second slave console 220b. In some embodiments, the master console 210 can also include one or more foot pedal(s) or other actuator(s), which can be depressed to engage or release a clutch. When the clutch is engaged (e.g., by depressing the one or more foot pedal(s)), the master controller 214 can be configured to send instructions that cause the slave consoles 220a, 220b to replicate movements of the master manipulators 212a, 212b. And when the clutch is not engaged, the master controller 214 may pause sending instruction to the slave consoles 220a, 220b, such that the slave consoles 220a, 220b do not replicate the movements of the master manipulators 212a, 212b and/or deactivate the movement of the slave console(s) 220a, 220b in some other manner.



FIG. 4 depicts the sterile zones or regions of the surgical robotic system 200, according to embodiments. As shown, the master console can include a first sterile zone 211a, a second sterile zone 211b, and a third sterile zone 215. The first sterile zone 211a can cover the first master manipulator 212a (e.g., a left master manipulator), and the second sterile zone 211b can cover the second master manipulator 212b (e.g., a right master manipulator). A first sterile handle 216a can be removably coupled to the first master manipulator 212a at a first sterile coupling interface 213a, and a second sterile handle 216b can be removably coupled to the second master manipulator 212b at a second sterile coupling interface 213b. The third sterile zone 215 can cover a master controller and/or display unit. The master console 210 can also include components or surfaces 219 outside of the first, second and third sterile zones 211a, 211b, 215 that are disposed in a non-sterile zone 204. For example, the master console 210 can include one or more transport elements (e.g., wheels) and foot pedals 218 that are disposed outside of the sterile zones 211a, 211b, 215.


A first slave console 220a (e.g., a left slave console) may include a sterile zone 221a (e.g., a fourth sterile zone). A sterile instrument 228a can be removably couplable to the first slave console 220a (and specifically, a slave manipulator of the first slave console 220a) at a sterile coupling interface 223a. The sterile coupling interface 223a can allow the sterile instrument 228a to be coupled to and decoupled from the first slave console 220a without compromising the sterile zone 221a of the first slave console 220a. A second slave console 220b (e.g., a right slave console) may include a sterile zone 220b (e.g., a fifth sterile zone). A sterile instrument 228b can be removably couplable to the second slave console 220b (and specifically, a slave manipulator of the second slave console 220b) at a sterile coupling interface 223b. The sterile coupling interface 228b can allow the sterile instrument 228b to be coupled to and decoupled from the second slave console 220b without compromising the sterile zone 221b of the second slave console 220b. The first and second slave consoles 220a, 220b can also include components or surfaces 229a, 229b, respectively, that are disposed outside of the sterile zones 221a, 221b. For example, the slave consoles 220a, 220b can include one or more transport elements 229a, 229b (e.g., wheels) that are disposed outside of the sterile zones 221a, 221b.


The endoscopic device 230 can include a sterile zone 231 (e.g., a sixth sterile zone) and one or more non-sterile components or surfaces 239.



FIG. 5 provides a more detailed view of an instrument 328 and an instrument coupling interface 323 of a surgical robotic system, according to embodiments. The instrument 328 can be structurally and/or functionally similar to other instruments described herein (e.g., instruments 228a, 228b), and the coupling interface 323 can be structurally and/or functionally similar to other coupling interfaces described herein (e.g., coupling interfaces 223a, 223b).


As shown in FIG. 5, the instrument 328 can be coupled to a slave manipulator 322 of a slave console. The slave manipulator 322 can include a plurality of links interconnected by a plurality of joints. The slave manipulator 322 can terminate at an instrument hub 325, which can define an opening through which the instrument 328 can be received. The slave manipulator 322 and the instrument hub 325 can be non-sterile components of the surgical robotic system and therefore be covered by a sterile drape during a surgical operation. To maintain sterility while coupling and uncoupling a sterile instrument to the slave manipulator 322, a sterile coupling interface 323 can be coupled to the instrument hub 325. In particular, the sterile coupling interface 323 can be inserted within the opening of the instrument hub 325 and provide an interface for engaging with the instrument 328. The sterile coupling interface 323 can define a lumen or opening for receiving the instrument 328.


The instrument 328 can include a head 327 at a proximal region of the instrument 328, an end effector 329 at a distal region of the instrument, and a shaft 326 extending therebetween. The head 327 and/or shaft 326 can define one or more lumens, e.g., for receiving one or more other components such as, for example, electrical cables for coupling an electrosurgical generator with the end effector 329 and/or cables for actuating the end effector 329. The instrument 328 can be sized and shaped to be inserted through the lumen or opening of the sterile coupling interface 323. Further examples of instruments and coupling interfaces are described in U.S. patent application Ser. No. 15/976,812, filed May 10, 2018, titled “Translational Instrument Interface for Surgical Robot and Surgical Robot Systems Comprising the Same,” the disclosure of which is incorporated herein by reference.



FIG. 6 provides a detailed view of the proximal side of the instrument 328 when inserted within the sterile coupling interface 323, according to embodiments. When the instrument 328 is received within the sterile coupling interface 323, the instrument 328 can be coupled to one or more drive units and/or actuators of the slave console. The one or more drive units and/or actuators of the slave console can then control movement of the end effector 329 in one or more DOFs. In some embodiments, the one or more actuators can include linear actuators that can translate to actuate movement of the end effector 329 in a plurality of DOFs.


During a surgical operation, the one or more drive units and/or actuators of the slave console may drive movement of the end effector 329 of the instrument 328 to perform a surgical task, such as, for example, grasping tissue and/or gripping a needle, suture or other object. When the surgical operation is interrupted, e.g., due to a non-critical temporary interruption, the surgical robotic system may not be easily restarted if the instrument 328 (or other instruments coupled to the surgical robotic system) is blocked inside of the patient (e.g., grasped onto patient tissue and/or gripped onto a needle, suture, or other object). In these instances, the instrument 328 may need to be released first (e.g., released from the tissue, needle, or suture) under controlled conditions before surgical robotic system can be restarted. If the instrument 328 is blocked inside of the patient while tissue is grasped, uncontrolled motion to release the instrument may cause damages to the patient.


In some embodiments, the surgical robotic system may include one or more emergency release features 351. The emergency release features 351 may be cavities that can receive an emergency release tool, such as the tool 350 shown in FIG. 7. The tool 350 can be inserted into the cavities to allow one or more actuators of the instrument 328 to move to release the end effector 329. As depicted in FIG. 7, the emergency release tool 350 can be a screwdriver with a tip sized and shaped for insertion into the cavities. While a screwdriver is depicted, it can be appreciated that any elongate member or shaft that has an end shaped to be inserted into the cavities can be used to release the instrument 328. While the emergency release tool 350 may provide a way to release the instrument 328, the use of the emergency release tool 350 may compromise the sterility of the surgical robotic system. In particular, the emergency release features 351 may be disposed on the slave manipulator 322 and/or sterile interface 323 behind a surgical drape. Therefore, when the emergency release tool 350 is inserted into the cavities, the tool 350 may breach the sterile barrier and compromise the sterility of the surgical robotic system. To resume the surgical operation, sterility would then need to be restored by exchanging the sterile coupling interface 323 and the sterile drape, which can lead to significant delays. In some instances, when multiple instruments 328 coupled to multiple slave consoles are locked within the patient, the use of the emergency release tool 350 at each of the slave consoles would require sterility to be restored at each of the slave consoles before the surgical operation can be resumed. As such, an improved instrument release procedure that does not compromise the sterility of the surgical robotic system may be desired, as further described below.


After an unexpected interruption, it may also be necessary to restart the various components of the surgical robotic system before resuming the surgical operation. For example, each of the slave consoles that are in use may need to be restarted before the surgical operation can resume. In some embodiments, a slave console can include a switch or other actuator for restarting. For example, as depicted in FIG. 8, a slave console 420 may include a power supply switch 422 that can be manually actuated, e.g., by a user, to restart the slave console 420. In particular, actuating the power supply switch 422 can cycle power off and on to the slave console 420. The switch 422, however, may be difficult for a user to access. Due to space constraints within an operating room and/or to avoid accidental actuation of the switch, the switch 422 may need to be placed at a location that is more concealed or secluded location. In some embodiments, the switch 422 may also be placed at a non-sterile location, e.g., near a bottom of the slave console 420. While the switch 422 at this location is unlikely to be accidentally actuated and is out of the way of other moving components of the slave console 420, actuation of the switch 422 may compromise the sterility of the user and necessitate a new sterile setup. Such can lead to significant delays before the surgical operation can be resumed. As such, an improved restart procedure that is easier to initiate and does not compromise the sterility of the surgical robotic system may be desired, as further described below.


Systems, devices, and methods described herein provide mechanisms for restarting a surgical robotic system and/or releasing one or more surgical instruments without compromising sterility. The restart procedure can be initiated or performed from a sterile area of a surgical robotic system. If any instruments are blocked within a patient, then the restart procedure can include or be followed by an instrument release procedure, whereby an instrument can be actuated to release from patient tissue and/or other objects within a patient without compromising the sterility of the surgical robotic system and/or components and accessories thereof or the sterility of users within the operating room.



FIG. 9 depicts an example master console 510 of a surgical robotic system, where the master console 510 includes functions for implementing a restart procedure, according to embodiments. The master console 510 can be structurally and/or functionally similar to other master consoles described herein, including, for example, master console 110, 210, etc. For example, the master console 510 can include a first master manipulator 512a (e.g., a left master manipulator), a second master manipulator 512b (e.g., a right master manipulator), and a display 519. The master console 510 can also include a restart. The restart can be implemented as one or more physical actuators, such as one or more buttons, switches, sliders, pedals, knobs, wheels, etc. As depicted in FIG. 9 in greater detail in FIG. 10, the master console 510 can include two sets of buttons 516, 517. The set of buttons 516 can include two buttons 516a, 516b, and the set of buttons 517 can include a single button. Alternatively, or additionally, the restart can be implemented as a virtual element, such as, for example, a virtual button, a virtual slider, a virtual switch, etc. The virtual element can be presented to a user via a display, e.g., display 519. Still alternatively, or additionally, the restart can be implemented via audio recognition (e.g., by a user speaking a specific command to a microphone), gesture recognition (e.g., by a user gesturing to an image capture device), or the like.


Importantly, the restart can be activated or actuated by a sterile user within the sterile field without comprising sterility. In the example depicted in FIG. 9, the restart implemented as one or more sets of buttons 516, 517 is located within a sterile zone or region 503 of the master console 510. The sterile zone 503 can be established using one or more surgical drapes, e.g., similar to that described above with reference to FIG. 4. Surgical drapes, however, typically do not extend to the floor of an operating room, and therefore at least a region 504 of the master console 510 may remain un-draped and therefore non-sterile. The one or more buttons 516, 517 can be located on the master console 510 in the sterile zone 503 such that a user can actuate or activate the sets of buttons 516, 517 without compromising sterility. For example, a user can press or push on one or more buttons from the sets of buttons 516, 517 through the sterile drape without breaching (e.g., breaking or damaging) the sterile drape. Therefore, when the surgical robotic system is temporarily interrupted and requires a restart, a sterile operator (e.g., surgeon or other user) can restart the surgical robotic system by pressing one or more buttons from the sets of buttons 516, 517.


In some embodiments, the sets of buttons 516, 517 may need to be pressed according to a predefined combination or sequence before activating a restart. For example, one or more buttons may need to be pressed concurrently or sequentially for a predefined period of time (e.g., between about 2 seconds and about 10 seconds, inclusive of all sub-ranges and values) to activate the restart. In some embodiments, a single button may need to be pressed for a predefined period of time (e.g., between about 2 seconds and about 10 seconds, inclusive of all sub-ranges and values) to activate the restart. Having a specific combination or sequence can avoid an accidental restart. In some embodiments, activation of the restart may not initiate a restart process until certain conditions are present. For example, activation of the restart (e.g., pressing the button(s) 516, 517) may not initiate the restart process when the surgical robotic system is not in an interrupted state (e.g., when the surgical robotic system is operating normally, or when the surgical robotic system is powered off).


In some embodiments, activation of the restart can restart the entire surgical robotic system, e.g., including the master console 510, one or more slave consoles, and/or an endoscopic device. In other words, the restart of the entire surgical robotic system can be activated using one centralized command. Alternatively, or additionally, one or more components of the surgical robotic system can be selectively restarted, e.g., based on actuation of different combinations or sequences of one or more restart elements. For example, pressing on a button 517 located at or near master manipulator 512a may activate a restart of a left slave console, while pressing on a button 516a or 516b located at or near master manipulator 512b may activate a restart of a right slave console. Such selectively may be useful in instances where a first slave console may have been temporarily interrupted while a second slave console has not been temporarily interrupted.


While the restart is shown as being located on the master console 510 in the example embodiment depicted in FIGS. 9 and 10, it can be appreciated that the restart can be located at any other location within a sterile zone of the surgical robotic system (e.g., any one of sterile zones 211a, 211b, 215, 221a, 221b, 231 depicted in FIG. 4).



FIGS. 11-13 depict various methods of restarting a surgical robotic system while maintaining sterility, according to embodiments. FIGS. 11 and 12 depict a method 600 involving a restart procedure and an instrument release procedure. FIG. 13 depicts a method 700 involving only a restart procedure. The methods 600 and 700 can be implemented by any of the surgical robotic systems described herein, including, for example, surgical robotic system 100, 200, etc. In particular, the methods 600 and 700 can be implemented by one or more processors and/or controllers (e.g., master controller(s) 114, slave controller(s) 124, etc.) of the surgical robotic system.


In some embodiments, a surgeon or other operator within the operating room may control which procedure is implemented by the surgical robotic system. When the surgical robotic system is unexpectedly or temporarily interrupted, the surgical robotic system can be in one of three states of operation. In a first state, the surgical robotic system may not have any instruments present (i.e., no instruments are coupled to the slave manipulators of the surgical robotic system). In such instances, the user can activate a restart, and the surgical robotic system can proceed with restarting according to method 700. In a second state, the surgical robotic system may have one or more instruments present (i.e., one or more instruments are coupled to one or more slave manipulators of the surgical robotic system), but the one or more instruments may not be active or blocked within a patient. In such cases, the instruments do not need to be released and therefore the user may choose to remove the instruments before activating the restart. If the restart is activated without any instruments, then the surgical robotic system can proceed with restarting according to method 700. If there are still instruments present, then the surgical robotic system can proceed with restarting according to method 600. In a third state, the surgical robotic system may have one or more instruments present, and at least one of those instruments may be active or blocked within a patient. In such cases, the user can remove any inactive instruments first and then activate the restart. When the restart is activated, then surgical robotic system can proceed with restarting according to method 600 to release the one or more active instruments.


Referring now to FIG. 11, at 602, the surgical robotic system may detect that a restart has been activated. For example, the surgical robotic system may detect that a user has pressed a restart button or other type of physical actuator. Alternatively, or additionally, the surgical robotic system may detect that a user has actuated or activated a virtual element, such as, for example, a button, slider, switch. Still alternatively, or additionally, the surgical robotic system may detect that a user has spoken a specific command (e.g., as captured by an audio device), made a specific gesture (e.g., as captured by an image capture device), and/or made some other type of indication associated with activating the restart.


At 603, the surgical robotic system may optionally, in response to detecting that the restart has been activated, determine whether restarting is allowed. For example, the surgical robotic system may determine whether certain conditions are present that necessitate a restart. In some embodiments, a restart may only be allowed when one or more components of the surgical robotic system have experienced a temporary interruption. A temporary interruption can be caused by one or more abnormal events or conditions, including, for example, (1) an unexpected movement of a slave manipulator (e.g., a joint or link of a slave manipulator), (2) an unexpected movement of the master console (e.g., the master manipulator or another portion of the master console), (3) an input anomaly associated with the master console (e.g., too fast of a movement of the master manipulator, too high acceleration of the master manipulator, lost of integrity, sensor failure), (4) a collision between a portion of the surgical robotic system (e.g., one or more links of the slave manipulator and/or the instrument) and an external object, or (5) a failure of a sensor, actuator, or controller of the surgical robotic system. When the surgical robotic system is interrupted, it may enter into a safe mode, whereby controlled movement of the slave manipulators by the master console (i.e., telemanipulation of the slave manipulators) may be deactivated. Therefore, in some embodiments, the surgical robotic system may determine whether it is operating in a safe mode, at 603. If the surgical robotic system determines that at least a portion of the surgical robotic system has been temporarily interrupted (e.g., is operating in a safe mode), then the method 600 continues to 604. Alternatively, if the surgical robotic system determines that it is operating normally or has not been interrupted, then the surgical robotic system may continue its normal operation, at 614.


At 604, the surgical robotic system may determine whether an instrument is active. In some embodiments, the surgical robotic system may determine whether an instrument is active by determining whether an instrument is coupled to any one of the slave manipulators of the surgical robotic system. For example, when an instrument is coupled to one of the slave manipulators, then the surgical robotic system may assume that the instrument is active and can proceed to implementing an instrument release procedure, at 606. Alternatively, if no instrument is coupled to a slave manipulator, then the surgical robotic system can proceed to restarting the surgical robotic system, at 612. In some embodiments, the surgical robotic system may determine whether an instrument is active by determining whether an instrument is disposed within a patient. For example, the surgical robotic system may use one or more sensors to determine that an instrument is located within a patient. When an instrument is disposed within a patient, the surgical robotic system may then proceed to implementing an instrument release procedure, at 606. When no instrument is disposed within the patient, then the surgical robotic system may proceed, optionally, to unlocking the instruments, at 610, or to restarting the surgical robotic system, at 612.


At 606, when there is at least one active instrument, the surgical robotic system can implement an instrument release. The surgical robotic system can implement an instrument release by allowing for controlled movement by the master console or telemanipulation of the instrument in a limited or reduced set of DOFs. In embodiments where the instrument includes a set of jaws, the surgical robotic system may enable controlled movement of the instrument in one or two DOFs, including, for example, a first DOF that allows a first jaw to move (e.g., pivot or translate) relative to a second jaw and/or a second DOF that allows the second jaw to move relative to the first jaw. In embodiments where the instrument includes a hook, a scalpel, a spatula, a needle holder, a dissector, a scissor, or a grasper, the surgical robotic system may enable controlled movement of the instrument in one or two DOFs that allows the hook, scalpel, spatula, needle holder, dissector, scissor, or grasper to engage in translational and/or rotational movement. Further details of an example instrument release procedure are described below with reference to FIG. 12.


In some embodiments, the surgical robotic system can implement further engagement of an instrument with patient tissue or other components within a patient. For example, the surgical robotic system may allow for controlled movement by the master console or telemanipulation of the instrument in a limited or reduced set of DOFs that allows the instrument to increase its engagement with patient tissue and/or other components. This can be desirable when a patient is bleeding or when other emergency action may need to be taken within a patient before an instrument is to be released. For example, the instrument can be engaged further with patient tissue to apply pressure to stop bleeding.


Where there are multiple instruments that are coupled to the surgical robotic system (e.g., coupled to one or more slave manipulators of the surgical robotic system), the surgical robotic system may enable instrument release and/or further engagement of the multiple instruments concurrently and/or sequentially. When all instruments have been released, at 608, the method 600 can continue, optionally, to 610 or continue to 612.


In some embodiments, the one or more instruments coupled to the surgical robotic system may be locked in engagement with the slave manipulators, e.g., by one or more locking mechanism(s). In such embodiments, the one or more instruments may need to be released (e.g., the locking mechanism(s) may need to be released) so that the instruments can be removed from the slave manipulators. In some embodiments, the surgical robotic system may optionally unlock the instruments, at 610, such that a sterile user can remove the instruments from the slave manipulators. Alternatively, or additionally, the instruments can be manually unlocked by a user and removed from the slave manipulators.


At 612, the surgical robotic system can automatically restart. In some embodiments, restarting the surgical robotic system can include powering off and on (i.e., power cycling) each component of the surgical robotic system. For example, the master console, each of the slave consoles, and/or the endoscopic device can be powered off and then back on. Optionally, in some embodiments, after powering off and on the surgical robotic system, one or more components of the surgical robotic system may be placed back in a starting or home position. For example, one or more slave manipulators of the surgical robotic system may be placed back in a home position.


At 614, the surgical robotic system may then continue its operation. For example, one or more instruments may be inserted back into the slave manipulators and then the surgical procedure can resume.



FIG. 12 provides a more detailed view of implementing 606 of method 600, according to embodiments. At 620, the surgical robotic system can initiate one or more predefined actuation functions associated with one or more instruments. For example, the surgical robotic system can activate controlled movement by the master console of an instrument in a limited or reduced set of DOFs, as described above. After activating the controlled movement, the surgical robotic system may detect an actuation of one or more handle(s) at the master console, at 622. Optionally, the surgical robotic system may also detect that one or more pedals or other mechanisms for engaging the clutch has been released, at 624. The surgical robotic system may then control the movement of the instrument based on the detected actuation of the handle(s), at 626.


In some embodiments, the surgical robotic system may prevent the user from applying an unintended force on grabbed tissue when taking control of the instrument actuation. In such embodiments, the user may need to first close a handle at the master console and then open the handle until the handle position (or command associated therewith) matches or corresponds to the current position of the instrument (i.e., the position of the instrument when it was interrupted). In response to the handle position matching the current position of the instrument, the actuation of the instrument may then activate and the movement of the handle can be replicated at the instrument. Therefore, in such embodiments, only an opening movement can be the first movement that is replicated. Subsequent movements following the opening of the instrument can then include closing of the instrument (e.g., under visual guidance). Alternatively, in some embodiments (e.g., such as those involving dissention or anastomosis where a vessel may be held open with one or more jaws), the surgical robotic system may require the first movement to be a closing movement.



FIG. 13 depicts method 700 for implementing a sterile restart of the surgical robotic without an instrument release, according to embodiments. At 702, the surgical robotic system may detect that a restart has been activated, similar to 602 of method 600. Optionally, at 703, the surgical robotic system may determine whether restarting is allowed, similar to 603 of method 600. When restarting is allowed, the surgical robotic system may proceed with restarting, at 712, similar to 612 of method 600. When restarting is not allowed, the surgical robotic system may continue its normal operation, at 714, similar to 614 of method 600.


While various inventive embodiments have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the function and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the inventive embodiments described herein. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the inventive teachings is/are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific inventive embodiments described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto; inventive embodiments may be practiced otherwise than as specifically described and claimed. Inventive embodiments of the present disclosure are directed to each individual feature, system, article, material, and/or method described herein. In addition, any combination of two or more such features, systems, articles, materials, and/or methods, if such features, systems, articles, materials, and/or methods are not mutually inconsistent, is included within the inventive scope of the present disclosure.


Also, various inventive concepts may be embodied as one or more methods, of which an example has been provided. The acts performed as part of the method may be ordered in any suitable way. Accordingly, embodiments may be constructed in which acts are performed in an order different than illustrated, which may include performing some acts simultaneously, even though shown as sequential acts in illustrative embodiments.


As used herein, the terms “about” and/or “approximately” when used in conjunction with numerical values and/or ranges generally refer to those numerical values and/or ranges near to a recited numerical value and/or range. In some instances, the terms “about” and “approximately” may mean within ±10% of the recited value. For example, in some instances, “about 100 [units]” may mean within ±10% of 100 (e.g., from 90 to 110). The terms “about” and “approximately” may be used interchangeably.


The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”

Claims
  • 1. An apparatus, comprising: a restart of a surgical robotic system that is configured to be activated by a sterile user from within a sterile field without compromising the sterile field; anda controller operatively coupled to the restart, the controller being configured to: detect that the restart has been activated;in response to detecting that the restart has been activated, determine whether an instrument is coupled to a slave manipulator of the surgical robotic system; andin response to determining that the instrument is coupled to the slave manipulator, enable telemanipulation of the instrument in a predefined set of degrees-of-freedom (DOFs) that allows the instrument to engage further with or disengage from tissue or other components within a body of a patient without compromising the sterile field.
  • 2. The apparatus of claim 1, wherein the restart includes one or more physical or virtual buttons, switches, or sliders.
  • 3. The apparatus of claim 2, wherein the controller is configured to detect that the restart has been activated when the one or more physical or virtual buttons, switches, or sliders have been activated for a predefined period of time.
  • 4. The apparatus of claim 3, wherein the controller is configured to provide haptic, audible, or visual feedback while or after the one or more physical or virtual buttons, switches, or sliders have been activated.
  • 5. The apparatus of claim 1, wherein the restart includes a plurality of buttons, switches, or sliders.
  • 6. The apparatus of claim 5, wherein the controller is configured to detect that the restart has been activated when the plurality of buttons, switches, or sliders has been activated according to a predefined sequence.
  • 7. The apparatus of claim 1, wherein the instrument includes a set of jaws, and the predefined set of DOFs that allows the instrument to be engaged further with or disengaged from the tissue or other components is one or more DOFs that allow the set of jaws to open or close.
  • 8. The apparatus of claim 1, wherein the instrument includes a hook, scalpel, spatula, needle holder, dissector, scissors, or grasper, and the predefined set of DOFs that allows the instrument to be engaged further with or disengaged from the tissue or other components is a DOF associated with a rotational motion of the hook, scalpel, spatula, needle holder, dissector, scissors, or grasper.
  • 9. The apparatus of claim 1, wherein the restart is located on a master console of the surgical robotic system.
  • 10. The apparatus of claim 1, wherein the restart is located on the slave manipulator.
  • 11. The apparatus of claim 1, wherein the controller is further configured to, after the instrument has been disengaged from the tissue or other components, restart the robotic system.
  • 12. The apparatus of claim 11, wherein the controller is further configured to return the slave manipulator to a home position after restarting the robotic system.
  • 13. The apparatus of claim 1, wherein the controller is further configured to: detect, during a surgical procedure, an abnormal event; andin response to detecting the abnormal event, deactivate the slave manipulator from movement.
  • 14. The apparatus of claim 1, wherein the controller is further configured to: deactivate, in response to detecting an abnormal event, teleoperation of the slave manipulator and the instrument coupled to the slave manipulator by a user-operated device at a master console of the surgical robotic system.
  • 15. The apparatus of claim 14, wherein the abnormal event includes at least one of: unexpected movement of at least one of the slave manipulator or the instrument, an input anomaly associated with the master console, a collision between (1) at least one of the slave manipulator or the instrument and (2) an external object, or a failure of a sensor, actuator, or controller of the surgical robotic system.
  • 16. The apparatus of claim 1, further comprising a master console disposed separately from the slave manipulator, wherein the master console includes a first plurality of links that are operatively coupled to a second plurality of links of the slave manipulator such that movements of the first plurality of links cause corresponding movements of the second plurality of links, wherein the restart is located on the master console proximate to the first plurality of links.
  • 17. The apparatus of claim 16, further comprising a sterile handle configured to be removably coupled to the master console, wherein the sterile handle, when coupled to the master console, is configured to control telemanipulation of the instrument in the predefined set of degrees-of-freedom.
  • 18. The apparatus of claim 16, further comprising a sterile barrier configured to isolate the master console from the sterile field, the restart being located on the master console behind the sterile barrier.
  • 19. The apparatus of claim 1, wherein the slave manipulator is a first slave manipulator, and the instrument is a first instrument, the controller further configured to: in response to detecting that the restart has been activated, determine whether a second instrument is coupled to a second slave manipulator of the surgical robotic system; andin response to determining that the second instrument is coupled to the second slave manipulator, enabling telemanipulation of the second instrument in a predefined set of DOFs after enable telemanipulation of the first instrument.
  • 20. The apparatus of claim 1, wherein the controller is configured to enable telemanipulation of the instrument in a predefined set of DOFs by enabling telemanipulation of the instrument to open before enabling telemanipulation of the instrument in any other DOFs.
CROSS-REFERENCE TO RELATED APPLICATION

This is a division of U.S. patent application Ser. No. 18/167,779, filed Feb. 10, 2023, now U.S. Pat. No. 11,844,585, the contents of which are incorporated herein by reference.

US Referenced Citations (470)
Number Name Date Kind
2764301 Goertz et al. Sep 1956 A
2771199 Jelatis Nov 1956 A
2774488 Goertz et al. Dec 1956 A
2846084 Goertz et al. Aug 1958 A
3065863 Saunders, Jr. Nov 1962 A
3095096 Chesley Jun 1963 A
3212651 Specht et al. Oct 1965 A
3261480 Haaker et al. Jul 1966 A
3297172 Haaker et al. Jan 1967 A
3391801 Haaker Jul 1968 A
3425569 Haaker Feb 1969 A
4221516 Haaker et al. Sep 1980 A
4522196 Cunningham et al. Jun 1985 A
4756655 Jameson Jul 1988 A
5147357 Rose et al. Sep 1992 A
5176352 Braun Jan 1993 A
5207114 Salisbury, Jr. et al. May 1993 A
5209747 Knoepfler May 1993 A
5304203 El-Mallawany et al. Apr 1994 A
5308358 Bond et al. May 1994 A
5330502 Hassler et al. Jul 1994 A
5368606 Marlow et al. Nov 1994 A
5383888 Zvenyatsky et al. Jan 1995 A
5484435 Fleenor et al. Jan 1996 A
5591119 Adair Jan 1997 A
5599151 Daum et al. Feb 1997 A
5603723 Aranyi et al. Feb 1997 A
5631973 Green May 1997 A
5649955 Hashimoto et al. Jul 1997 A
5649956 Jensen et al. Jul 1997 A
5709219 Chen et al. Jan 1998 A
5710870 Ohm et al. Jan 1998 A
5716352 Viola et al. Feb 1998 A
5735874 Measamer et al. Apr 1998 A
5779727 Orejola Jul 1998 A
5784542 Ohm et al. Jul 1998 A
5792045 Adair Aug 1998 A
5797900 Madhani et al. Aug 1998 A
5810716 Mukherjee et al. Sep 1998 A
5810805 Sutcu et al. Sep 1998 A
5828813 Ohm Oct 1998 A
5908436 Cuschieri et al. Jun 1999 A
5931832 Jensen Aug 1999 A
5951587 Qureshi et al. Sep 1999 A
5976122 Madhani et al. Nov 1999 A
6026701 Reboulet Feb 2000 A
6063095 Wang et al. May 2000 A
6132368 Cooper Oct 2000 A
6197017 Brock et al. Mar 2001 B1
6206903 Ramans Mar 2001 B1
6233504 Das et al. May 2001 B1
6281651 Haanpaa et al. Aug 2001 B1
6312435 Wallace et al. Nov 2001 B1
6331181 Tierney et al. Dec 2001 B1
6358249 Chen et al. Mar 2002 B1
6361534 Chen et al. Mar 2002 B1
6364879 Chen et al. Apr 2002 B1
6371952 Madhani et al. Apr 2002 B1
6375610 Verschuur Apr 2002 B2
6385509 Das et al. May 2002 B2
6394998 Wallace et al. May 2002 B1
6435794 Springer Aug 2002 B1
6436107 Wang et al. Aug 2002 B1
6459926 Nowlin et al. Oct 2002 B1
6491701 Tierney et al. Dec 2002 B2
6504456 Iio et al. Jan 2003 B2
6554844 Lee et al. Apr 2003 B2
6587750 Gerbi et al. Jul 2003 B2
6594552 Nowlin et al. Jul 2003 B1
6659939 Moll et al. Dec 2003 B2
6671581 Niemeyer et al. Dec 2003 B2
6699177 Wang et al. Mar 2004 B1
6786896 Madhani Sep 2004 B1
6788999 Green Sep 2004 B2
6799065 Niemeyer Sep 2004 B1
6840938 Morley et al. Jan 2005 B1
6850817 Green Feb 2005 B1
6852107 Wang et al. Feb 2005 B2
6879880 Nowlin et al. Apr 2005 B2
6902560 Morley et al. Jun 2005 B1
6913613 Schwarz et al. Jul 2005 B2
6951535 Ghodoussi et al. Oct 2005 B2
6991627 Madhani et al. Jan 2006 B2
6994708 Manzo Feb 2006 B2
7025064 Wang et al. Apr 2006 B2
7048745 Tierney et al. May 2006 B2
7083571 Wang et al. Aug 2006 B2
7090637 Danitz et al. Aug 2006 B2
7101363 Nishizawa et al. Sep 2006 B2
7122032 Shinmura et al. Oct 2006 B2
7204836 Wagner et al. Apr 2007 B2
7206627 Abovitz et al. Apr 2007 B2
7214230 Brock et al. May 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7241289 Braun Jul 2007 B2
7306597 Manzo Dec 2007 B2
7316681 Madhani et al. Jan 2008 B2
7338513 Lee et al. Mar 2008 B2
7364582 Lee Apr 2008 B2
7373219 Nowlin et al. May 2008 B2
7398707 Morley et al. Jul 2008 B2
7481824 Boudreaux et al. Jan 2009 B2
7549998 Braun Jun 2009 B2
7594912 Cooper et al. Sep 2009 B2
7604642 Brock Oct 2009 B2
7608039 Todd Oct 2009 B1
7615002 Rothweiler et al. Nov 2009 B2
7615067 Lee et al. Nov 2009 B2
7674255 Braun Mar 2010 B2
7695481 Wang et al. Apr 2010 B2
7699855 Anderson et al. Apr 2010 B2
7713190 Brock et al. May 2010 B2
7756036 Druke et al. Jul 2010 B2
7819894 Mitsuishi et al. Oct 2010 B2
7824401 Manzo et al. Nov 2010 B2
7828798 Buysse et al. Nov 2010 B2
7833156 Williams et al. Nov 2010 B2
7890211 Green Feb 2011 B2
7914521 Wang et al. Mar 2011 B2
7976458 Stefanchik et al. Jul 2011 B2
8048084 Schneid Nov 2011 B2
8105320 Manzo Jan 2012 B2
8114017 Bacher Feb 2012 B2
8137263 Marescaux et al. Mar 2012 B2
8142447 Cooper et al. Mar 2012 B2
8224485 Unsworth Jul 2012 B2
8246617 Welt et al. Aug 2012 B2
8267958 Braun Sep 2012 B2
8287469 Stefanchik et al. Oct 2012 B2
8292889 Cunningham et al. Oct 2012 B2
8306656 Schaible et al. Nov 2012 B1
8308738 Nobis et al. Nov 2012 B2
8332072 Schaible et al. Dec 2012 B1
8336751 Scirica Dec 2012 B2
8353898 Lutze et al. Jan 2013 B2
8357161 Mueller Jan 2013 B2
8382742 Hermann et al. Feb 2013 B2
8388516 Sholev Mar 2013 B2
8403832 Cunningham et al. Mar 2013 B2
8414475 Sholev Apr 2013 B2
8418904 Wenchell et al. Apr 2013 B2
8423186 Itkowitz et al. Apr 2013 B2
8433389 Geiger et al. Apr 2013 B2
8435171 Sholev May 2013 B2
8437754 Kubota et al. May 2013 B2
8444631 Yeung et al. May 2013 B2
8496152 Viola Jul 2013 B2
8518024 Williams et al. Aug 2013 B2
8523900 Jinno et al. Sep 2013 B2
8540748 Murphy et al. Sep 2013 B2
8560118 Greer et al. Oct 2013 B2
8562592 Conlon et al. Oct 2013 B2
8568444 Cunningham Oct 2013 B2
8579176 Smith et al. Nov 2013 B2
8591397 Berkelman et al. Nov 2013 B2
8597280 Cooper et al. Dec 2013 B2
8602287 Yates et al. Dec 2013 B2
8603077 Cooper et al. Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8617203 Stefanchik et al. Dec 2013 B2
8620473 Diolaiti Dec 2013 B2
8663270 Donnigan et al. Mar 2014 B2
8668689 Dumbauld et al. Mar 2014 B2
8668702 Awtar et al. Mar 2014 B2
8690755 Sholev Apr 2014 B2
8696666 Sanai et al. Apr 2014 B2
8709000 Madhani et al. Apr 2014 B2
8738181 Greer et al. May 2014 B2
8746252 McGrogan Jun 2014 B2
8761930 Nixon Jun 2014 B2
8763879 Shelton, IV et al. Jul 2014 B2
8768509 Unsworth Jul 2014 B2
8792688 Unsworth Jul 2014 B2
8801752 Fortier et al. Aug 2014 B2
8816628 Nowlin et al. Aug 2014 B2
8818560 Kishi Aug 2014 B2
8821480 Burbank Sep 2014 B2
8827135 Amid et al. Sep 2014 B2
8828046 Stefanchik et al. Sep 2014 B2
8845517 Russo Sep 2014 B2
8845622 Paik et al. Sep 2014 B2
8870049 Amid et al. Oct 2014 B2
8870867 Walberg et al. Oct 2014 B2
8887979 Mastri et al. Nov 2014 B2
8894674 Balanev et al. Nov 2014 B2
8919348 Williams et al. Dec 2014 B2
8930027 Schaible et al. Jan 2015 B2
8945098 Seibold et al. Feb 2015 B2
8961499 Paik et al. Feb 2015 B2
8961514 Garrison Feb 2015 B2
8968187 Kleyman et al. Mar 2015 B2
8989844 Cinquin et al. Mar 2015 B2
8992564 Jaspers Mar 2015 B2
9023015 Penna May 2015 B2
9033998 Schaible et al. May 2015 B1
9044238 Orszulak Jun 2015 B2
9052710 Farwell Jun 2015 B1
9084606 Greep Jul 2015 B2
9113860 Viola et al. Aug 2015 B2
9113861 Martin et al. Aug 2015 B2
9131986 Greer et al. Sep 2015 B2
9149339 Unsworth Oct 2015 B2
9192459 Bonutti Nov 2015 B2
9204939 Frimer et al. Dec 2015 B2
9216013 Scirica et al. Dec 2015 B2
9244523 Ogawa et al. Jan 2016 B2
9295379 Sholev Mar 2016 B2
9307894 Von Grünberg et al. Apr 2016 B2
9333040 Shellenberger et al. May 2016 B2
9345545 Shellenberger et al. May 2016 B2
9360934 Ruiz Morales et al. Jun 2016 B2
9421003 Williams et al. Aug 2016 B2
9474580 Hannaford et al. Oct 2016 B2
9480531 Von Grünberg Nov 2016 B2
9492240 Itkowitz et al. Nov 2016 B2
9603672 Shellenberger et al. Mar 2017 B2
9669542 Karguth et al. Jun 2017 B2
9696700 Beira et al. Jul 2017 B2
9730717 Katsuki et al. Aug 2017 B2
9757204 Frimer et al. Sep 2017 B2
9757206 Frimer et al. Sep 2017 B2
9763741 Alvarez et al. Sep 2017 B2
9782229 Crawford et al. Oct 2017 B2
9795282 Sholev et al. Oct 2017 B2
9795454 Seeber et al. Oct 2017 B2
9825455 Sandhu et al. Nov 2017 B2
9877794 Csiky Jan 2018 B2
D816243 Barber Apr 2018 S
9937013 Frimer et al. Apr 2018 B2
9943372 Sholev et al. Apr 2018 B2
10028792 Frimer et al. Jul 2018 B2
10039609 Frimer et al. Aug 2018 B2
10039820 Coller et al. Aug 2018 B2
10052157 Frimer et al. Aug 2018 B2
10064691 Frimer et al. Sep 2018 B2
10071488 Robinson et al. Sep 2018 B2
10085811 Weir et al. Oct 2018 B2
10092164 Sholev et al. Oct 2018 B2
10092359 Beira et al. Oct 2018 B2
10092365 Seeber Oct 2018 B2
10136956 Seeber Nov 2018 B2
10201392 Frimer et al. Feb 2019 B2
10265129 Beira Apr 2019 B2
10325072 Beira et al. Jun 2019 B2
10357320 Beira Jul 2019 B2
10357324 Flatt et al. Jul 2019 B2
10363055 Beira et al. Jul 2019 B2
10413374 Chassot et al. Sep 2019 B2
10500005 Weir et al. Dec 2019 B2
10510447 Beira et al. Dec 2019 B2
10548680 Beira Feb 2020 B2
10568709 Beira Feb 2020 B2
10646291 Turner May 2020 B2
10646294 Beira May 2020 B2
10786272 Beira Sep 2020 B2
10864049 Beira Dec 2020 B2
10864052 Beira Dec 2020 B2
10959792 Huang et al. Mar 2021 B1
11020191 Diolaiti Jun 2021 B2
11039820 Beira Jun 2021 B2
11058503 Chassot et al. Jul 2021 B2
11337716 Beira May 2022 B2
11478315 Beira Oct 2022 B2
11510745 Chassot et al. Nov 2022 B2
11571195 Beira Feb 2023 B2
11766301 Diolaiti Sep 2023 B2
11844585 Friedrich et al. Dec 2023 B1
20010020200 Das et al. Sep 2001 A1
20020040217 Jinno Apr 2002 A1
20020049367 Irion et al. Apr 2002 A1
20020072736 Tierney et al. Jun 2002 A1
20020082612 Moll et al. Jun 2002 A1
20030013949 Moll et al. Jan 2003 A1
20030155747 Bridges Aug 2003 A1
20030208186 Moreyra Nov 2003 A1
20040049205 Lee et al. Mar 2004 A1
20040116906 Lipow Jun 2004 A1
20040236316 Danitz et al. Nov 2004 A1
20040253079 Sanchez Dec 2004 A1
20050096502 Khalili May 2005 A1
20050204851 Morley et al. Sep 2005 A1
20050240078 Kwon et al. Oct 2005 A1
20060043698 Bridges Mar 2006 A1
20060079884 Manzo et al. Apr 2006 A1
20060178559 Kumar et al. Aug 2006 A1
20060183975 Saadat et al. Aug 2006 A1
20060219065 Jinno et al. Oct 2006 A1
20060235436 Anderson et al. Oct 2006 A1
20060253109 Chu Nov 2006 A1
20070088340 Brock et al. Apr 2007 A1
20070137371 Devengenzo et al. Jun 2007 A1
20070156123 Moll et al. Jul 2007 A1
20070208375 Nishizawa et al. Sep 2007 A1
20070299387 Williams et al. Dec 2007 A1
20080039255 Jinno et al. Feb 2008 A1
20080046122 Manzo et al. Feb 2008 A1
20080058776 Jo et al. Mar 2008 A1
20080065110 Duval Mar 2008 A1
20080071208 Voegele et al. Mar 2008 A1
20080103492 Morley et al. May 2008 A1
20080177285 Brock et al. Jul 2008 A1
20080215065 Wang et al. Sep 2008 A1
20080243106 Coe et al. Oct 2008 A1
20080287926 Abou El Kheir Nov 2008 A1
20080314181 Schena Dec 2008 A1
20090030449 Kawai et al. Jan 2009 A1
20090036902 DiMaio et al. Feb 2009 A1
20090192522 Blumenkranz Jul 2009 A1
20090198253 Omori Aug 2009 A1
20090216248 Uenohara et al. Aug 2009 A1
20090216249 Jinno et al. Aug 2009 A1
20090247821 Rogers Oct 2009 A1
20090248039 Cooper et al. Oct 2009 A1
20090275994 Phan et al. Nov 2009 A1
20090326552 Diolaiti Dec 2009 A1
20100004508 Naito et al. Jan 2010 A1
20100011900 Burbank Jan 2010 A1
20100023025 Zeiner et al. Jan 2010 A1
20100082041 Prisco Apr 2010 A1
20100094130 Ninomiya et al. Apr 2010 A1
20100121347 Jaspers May 2010 A1
20100160929 Rogers et al. Jun 2010 A1
20100160940 Lutze et al. Jun 2010 A1
20100170519 Romo et al. Jul 2010 A1
20100174410 Greer et al. Jul 2010 A1
20100225209 Goldberg et al. Sep 2010 A1
20100228249 Mohr et al. Sep 2010 A1
20100234857 Itkowitz et al. Sep 2010 A1
20100274087 Diolaiti Oct 2010 A1
20100286712 Won et al. Nov 2010 A1
20100305595 Hermann Dec 2010 A1
20100318099 Itkowitz et al. Dec 2010 A1
20100318101 Choi Dec 2010 A1
20100324551 Gerhardt Dec 2010 A1
20100331859 Omori Dec 2010 A1
20110071508 Duval Mar 2011 A1
20110087236 Stokes et al. Apr 2011 A1
20110087238 Wang et al. Apr 2011 A1
20110213346 Morley et al. Sep 2011 A1
20110230867 Hirschfeld et al. Sep 2011 A1
20110275901 Shelton, IV Nov 2011 A1
20110282359 Duval Nov 2011 A1
20110290854 Timm et al. Dec 2011 A1
20110301419 Craft et al. Dec 2011 A1
20120010628 Cooper et al. Jan 2012 A1
20120027762 Schofield Feb 2012 A1
20120031114 Mueller et al. Feb 2012 A1
20120049623 Nakayama Mar 2012 A1
20120071895 Stahler Mar 2012 A1
20120095298 Stefanchik et al. Apr 2012 A1
20120116163 Lutze et al. May 2012 A1
20120132018 Tang et al. May 2012 A1
20120143173 Steege et al. Jun 2012 A1
20120158014 Stefanchik et al. Jun 2012 A1
20120191245 Fudaba et al. Jul 2012 A1
20120203269 Katsuki et al. Aug 2012 A1
20120209292 Devengenzo et al. Aug 2012 A1
20120232339 Csiky Sep 2012 A1
20120253326 Kleyman Oct 2012 A1
20120277762 Lathrop et al. Nov 2012 A1
20120283745 Goldberg et al. Nov 2012 A1
20120283747 Popovic Nov 2012 A1
20120289973 Prisco et al. Nov 2012 A1
20120289974 Rogers et al. Nov 2012 A1
20120296341 Seibold et al. Nov 2012 A1
20130024024 Namiki Jan 2013 A1
20130123805 Park et al. May 2013 A1
20130144274 Stefanchik et al. Jun 2013 A1
20130172713 Kirschenman Jul 2013 A1
20130172906 Olson et al. Jul 2013 A1
20130204271 Brisson Aug 2013 A1
20130245643 Woodard, Jr. et al. Sep 2013 A1
20130245647 Martin et al. Sep 2013 A1
20130282027 Woodard, Jr. et al. Oct 2013 A1
20130303408 Indermuhle Nov 2013 A1
20130304083 Kaercher et al. Nov 2013 A1
20130304084 Beira et al. Nov 2013 A1
20140005681 Gee et al. Jan 2014 A1
20140018447 McGovern et al. Jan 2014 A1
20140018780 Hirscheld Jan 2014 A1
20140018960 Itkowitz Jan 2014 A1
20140052152 Au et al. Feb 2014 A1
20140076088 Berkelman et al. Mar 2014 A1
20140114481 Ogawa et al. Apr 2014 A1
20140121834 Ogawa et al. May 2014 A1
20140135794 Cau May 2014 A1
20140142595 Awtar et al. May 2014 A1
20140148950 Ogawa et al. May 2014 A1
20140166023 Kishi Jun 2014 A1
20140180308 Von Grünberg Jun 2014 A1
20140188091 Vidal et al. Jul 2014 A1
20140188159 Steege Jul 2014 A1
20140195010 Beira et al. Jul 2014 A1
20140200561 Ingmanson et al. Jul 2014 A1
20140207150 Rosa et al. Jul 2014 A1
20140229007 Kishi Aug 2014 A1
20140230595 Butt et al. Aug 2014 A1
20140249546 Shvartsberg et al. Sep 2014 A1
20140263541 Leimbach et al. Sep 2014 A1
20140263553 Leimbach et al. Sep 2014 A1
20140275961 Kassab et al. Sep 2014 A1
20140276950 Smaby et al. Sep 2014 A1
20140276956 Crainich et al. Sep 2014 A1
20140277017 Leimbach et al. Sep 2014 A1
20140350570 Lee Nov 2014 A1
20150057499 Erden et al. Feb 2015 A1
20150057702 Edmondson et al. Feb 2015 A1
20150060517 Williams Mar 2015 A1
20150066018 Doll et al. Mar 2015 A1
20150105821 Ward et al. Apr 2015 A1
20150113933 Markt Apr 2015 A1
20150142018 Sniffin et al. May 2015 A1
20150150575 Hartoumbekis et al. Jun 2015 A1
20150173840 Lohmeier Jun 2015 A1
20150230869 Shim et al. Aug 2015 A1
20150250547 Fukushima et al. Sep 2015 A1
20150265355 Prestel et al. Sep 2015 A1
20150272575 Leimbach et al. Oct 2015 A1
20160022365 Jensen et al. Jan 2016 A1
20160051274 Howell et al. Feb 2016 A1
20160151115 Karguth et al. Jun 2016 A1
20160220314 Huelman et al. Aug 2016 A1
20160235486 Larkin Aug 2016 A1
20160256155 Shelton, IV et al. Sep 2016 A1
20160302876 Teichtmann Oct 2016 A1
20160346053 Beira Dec 2016 A1
20160374766 Schuh Dec 2016 A1
20170020615 Koenig et al. Jan 2017 A1
20170020617 Weir et al. Jan 2017 A1
20170245954 Beira Aug 2017 A1
20170252096 Felder et al. Sep 2017 A1
20170265951 Grover et al. Sep 2017 A1
20170273749 Grover et al. Sep 2017 A1
20170308667 Beira et al. Oct 2017 A1
20170360522 Beira Dec 2017 A1
20170367778 Beira Dec 2017 A1
20180000472 Beira Jan 2018 A1
20180000544 Beira Jan 2018 A1
20180000550 Beira Jan 2018 A1
20180008358 Kostrzewski et al. Jan 2018 A1
20180028269 Morel et al. Feb 2018 A1
20180055583 Schuh et al. Mar 2018 A1
20180078439 Cagle et al. Mar 2018 A1
20180110576 Kopp Apr 2018 A1
20180125519 Beira et al. May 2018 A1
20180125592 Beira May 2018 A1
20180242991 Beira Aug 2018 A1
20180353252 Chassot et al. Dec 2018 A1
20180360548 Marshall et al. Dec 2018 A1
20190060012 Weir et al. Feb 2019 A1
20190090969 Jarc Mar 2019 A1
20190133698 Beira et al. May 2019 A1
20190175294 Abbott Jun 2019 A1
20190192245 Abbott Jun 2019 A1
20190239968 Beira Aug 2019 A1
20190239972 Chassot et al. Aug 2019 A1
20190314096 Diolaiti Oct 2019 A1
20190328473 Chassot et al. Oct 2019 A1
20200105412 Beira et al. Apr 2020 A1
20200275985 Thompson et al. Sep 2020 A1
20200390510 Thompson et al. Dec 2020 A1
20210093397 Huang et al. Apr 2021 A1
20210307737 Beira Oct 2021 A1
20210330407 Chassot et al. Oct 2021 A1
20210402603 Murphy et al. Dec 2021 A1
20230129956 Lyons et al. Apr 2023 A1
20230142404 Ariki et al. May 2023 A1
20230149002 Beira May 2023 A1
20230190396 Taheri et al. Jun 2023 A1
20230200629 Yang et al. Jun 2023 A1
Foreign Referenced Citations (131)
Number Date Country
101027010 Aug 2007 CN
101584594 Nov 2009 CN
101637402 Feb 2010 CN
101732093 Jun 2010 CN
103717355 Apr 2014 CN
111110350 May 2020 CN
4303311 Aug 1994 DE
19652792 May 1999 DE
10314827 Apr 2004 DE
10314828 Jul 2004 DE
102012222755 Jun 2014 DE
102014205036 Sep 2015 DE
102014205159 Sep 2015 DE
0595291 May 1994 EP
0621009 Oct 1994 EP
0677275 Oct 1995 EP
0776739 Jun 1997 EP
1254642 Nov 2002 EP
1279371 Dec 2004 EP
1886630 Feb 2008 EP
1889579 Feb 2008 EP
1889583 Feb 2008 EP
2058090 May 2009 EP
1977677 Aug 2009 EP
2095778 Sep 2009 EP
1889583 Apr 2011 EP
2377477 May 2012 EP
2473119 Jul 2012 EP
2305144 Oct 2012 EP
2044893 Jul 2013 EP
2653110 Oct 2013 EP
2679192 Jan 2014 EP
2736680 Jun 2014 EP
2777536 Sep 2014 EP
2777561 Sep 2014 EP
2783643 Oct 2014 EP
2837340 Feb 2015 EP
2837354 Feb 2015 EP
2554131 Aug 2015 EP
2777561 Oct 2015 EP
2979657 Feb 2016 EP
2837340 Oct 2016 EP
2783643 Jan 2019 EP
834244 May 1960 GB
969899 Sep 1964 GB
2004041580 Feb 2004 JP
2007290096 Nov 2007 JP
2008104620 May 2008 JP
2009018027 Jan 2009 JP
20110032444 Mar 2011 KR
20130031403 Mar 2013 KR
722754 Mar 1980 SU
WO-8200611 Mar 1982 WO
WO-9743942 Nov 1997 WO
WO-9825666 Jun 1998 WO
WO-03067341 Aug 2003 WO
WO-03086219 Oct 2003 WO
WO-2004052171 Jun 2004 WO
WO-2005009482 Feb 2005 WO
WO-2005046500 May 2005 WO
WO-2006086663 Aug 2006 WO
WO-2007133065 Nov 2007 WO
WO-2008130235 Oct 2008 WO
WO-2009091497 Jul 2009 WO
WO-2009095893 Aug 2009 WO
WO-2009145572 Dec 2009 WO
WO-2009157719 Dec 2009 WO
WO-2010019001 Feb 2010 WO
WO-2010030114 Mar 2010 WO
WO-2010050771 May 2010 WO
WO-2010083480 Jul 2010 WO
WO-2010096580 Aug 2010 WO
WO-2010130817 Nov 2010 WO
WO-2011025818 Mar 2011 WO
WO-2011027183 Mar 2011 WO
WO-2011123669 Oct 2011 WO
WO-2012020386 Feb 2012 WO
WO-2012049623 Apr 2012 WO
WO-2013007784 Jan 2013 WO
WO-2013014621 Jan 2013 WO
WO-2014012780 Jan 2014 WO
WO-2014018447 Jan 2014 WO
WO-2014067804 May 2014 WO
WO-2014094716 Jun 2014 WO
WO-2014094717 Jun 2014 WO
WO-2014094718 Jun 2014 WO
WO-2014094719 Jun 2014 WO
WO-2014139023 Sep 2014 WO
WO-2014145148 Sep 2014 WO
WO-2014156221 Oct 2014 WO
WO-2014201010 Dec 2014 WO
WO-2014201538 Dec 2014 WO
WO-2015081946 Jun 2015 WO
WO-2015081947 Jun 2015 WO
WO-2015088647 Jun 2015 WO
WO-2015088655 Jun 2015 WO
WO-2015111475 Jul 2015 WO
WO-2015113933 Aug 2015 WO
WO-2015129383 Sep 2015 WO
WO-2015139674 Sep 2015 WO
WO-2015175200 Nov 2015 WO
WO-2016030767 Mar 2016 WO
WO-2016083189 Jun 2016 WO
WO-2016097861 Jun 2016 WO
WO-2016097864 Jun 2016 WO
WO-2016097868 Jun 2016 WO
WO-2016097871 Jun 2016 WO
WO-2016097873 Jun 2016 WO
WO-2016154173 Sep 2016 WO
WO-2016162751 Oct 2016 WO
WO-2016162752 Oct 2016 WO
WO-2016183054 Nov 2016 WO
WO-2016189284 Dec 2016 WO
WO-2016209891 Dec 2016 WO
WO-2017015599 Jan 2017 WO
WO-2017037532 Mar 2017 WO
WO-2017064301 Apr 2017 WO
WO-2017064303 Apr 2017 WO
WO-2017064305 Apr 2017 WO
WO-2017064306 Apr 2017 WO
WO-2017134077 Aug 2017 WO
WO-2017220978 Dec 2017 WO
WO-2018142112 Aug 2018 WO
WO-2018162921 Sep 2018 WO
WO-2019099346 May 2019 WO
WO-2019155383 Aug 2019 WO
WO-2020026457 Feb 2020 WO
WO-2020131304 Jun 2020 WO
WO-2020141487 Jul 2020 WO
WO-2020263870 Dec 2020 WO
WO-2022175807 Aug 2022 WO
Non-Patent Literature Citations (35)
Entry
US 9,232,978 B2, 01/2016, Shellenberger (withdrawn)
Abbott, et al., “Design of an Endoluminal Notes Robotic System”, IEEE/RSJ International Conference on Intelligent Robots and Systems, 2007, San Diego, CA (pp. 410-416).
Aesculap Surgical Technologies, Aesculap.RTM. Caiman™, Advanced Bipolar Seal and Cut Technology Brochure, 6 pages (retrieved Aug. 31, 2015).
Arata, et al., “Development of a dexterous minimally-invasive surgical system with augmented force feedback capability”, IEEE/RSJ International Conference on Intelligent Robots and Systems, 2005 (pp. 3207-3212).
Cavusoglu, et al., “Laparoscopic Telesurgical Workstation”, IEEE Transactions on Robotics and Automation, (15)4:728-739 (1999).
Charles, et al., “Dexterity-enhanced Telerobotic Microsurgery”, 8th International Conference Advanced Robotics, pp. 5-10 (1997).
Dachs, et al., “Novel Surgical Robot Design: Minimizing the Operating Envelope With in the Sterile Field”, 28th International Conference, IEEE Engineering in Medicine Biology Society, 2006, New York (pp. 1505-1508).
Dario, et al., “Novel Mechatronic Tool for Computer-Assisted Arthroscopy,” IEEE Transactions on Information Technology in Biomedicine, 4(1 ): 15-29 (Mar. 2000).
Focacci, et al., “Lightweight Hand-held Robot for Laparoscopic Surgery”, IEEE International Conference on Robotics & Automation, Rome, Italy, pp. 599-604 (2007).
Guthart, et al., The Intuitive ™. “Telesurgery System: Overview and Application”, IEEE International Conference on Robotics & Automation, San Francisco, CA, 2000 (pp. 618-621 ).
Ikuta, et al., “Development of Remote Microsurgery Robot and New Surgical Procedure for Deep and Narrow Space”, IEEE International Conference on Robotics & Automation, Taipei, Taiwan, 2003 (pp. 1103-1108).
Ikuta, et al., “Hyper Redundant Miniature Manipulator ‘Hyper Finger’ for Remote Minimally Invasive Surgery in Deep Area”, IEEE International Conference on Robotics & Automation, Taipei, Taiwan, 2003 (pp. 1098-1102).
Ishii, et al., “Development of a New Bending Mechanism and Its Application to Robotic Forceps Manipulator”, IEEE International Conference on Robotics & Automation, Rome, Italy, 2007 (pp. 238-243).
Kobayashi, et al., “Small Occupancy Robotic Mechanisms for Endoscopic Surgery”, International Conference on Medical Image Computing and Computer assisted Interventions, 2002, (pp. 75-82).
Lang, et al., “Intra-operative robotics: NeuroArm.”, Acta Neurochir Suppl, 109:231-236 (2011 ).
Mayer, et al., “The Endo[PA]R System for Minimally Invasive Robotic Surgery”, IEEE/RSJ International Conference on Intelligent Robots and Systems, Sendai, Japan, 2004 (pp. 3637-3642).
Mitsuishi, et al., “Development of a Remote Minimally Invasive Surgical System with Operational Environment Transmission Capability”, IEEE International Conference on Robotics & Automation, Taipei, Taiwan, 2003, (pp. 2663-2670).
Mitsuishi, et al., “Master-Slave Robotic Platform and its Feasibility Study for Micro-Neurosurgery”, Int. J. Med. Robot., 9(2):180-9 (2013).
Morita, et al., “Microsurgical Robotic System for the Deep Surgical Field: development of a Prototype and Feasibility Studies in Animal and Cadaveric Models”, J. Neurosurg., 103(2):320-7 (2005).
Nakamura, et al., “Multi-DOF Forceps Manipulator System for Laparoscopic Surgery—Mechanism miniaturized & Evaluation of New Interface”, 4th International Conference on Medical Image Computing and Computer assisted Interventions (MICCAI2001 ), 2001 (pp. 606-613).
Non-Final Office Action dated Jul. 14, 2023, for U.S. Appl. No. 18/167,779, filed Feb. 10, 2023, 20 pages.
Notice of Allowance dated Aug. 8, 2023, for U.S. Appl. No. 18/167,779, filed Feb. 10, 2023, 10 pages.
Peirs, et al., “Design of an Advanced Tool Guiding System for Robotic Surgery,” IEEE International Conference on Robotics & Automation, Taipei, Taiwan, 2003, (pp. 2651-2656).
Salle, et al., “Optimal Design of High Dexterity Modular MIS Instrument for Coronary Artery Bypass Grafting”, IEEE International Conference on Robotics & Automation, New Orleans, LA, 2004, (pp. 1276-1281 ).
Seibold, et al., “Prototype of Instrument for Minimally Invasive Surgery with 6-Axis Force Sensing Capability”, IEEE International Conference on Robotics & Automation, Barcelona, Spain, 2005, (pp. 496-501 ).
Simaan, et al., “Dexterous System for Laryngeal Surgery: Multi-Backbone Bending Snake-like Slaves for Teleoperated Dexterous Surgical Tool Manipulation”, IEEE International Conference on Robotics & Automation, New Orleans, LA, 2004 (pp. 351-357).
Stryker™, Endoscopy, Take a Look Around, Ideal Eyes.TM. FFD122 HD, Articulating Laparoscope Brochure, 2 pages (2009).
Tavakoli, et al., “Force Reflective Master-Slave System for Minimally Invasive Surgery”, IEEE/RSJ International Conference on Intelligent Robots and Systems, Las Vegas, NV, 2003, (pp. 3077-3082).
Taylor, et al., “Steady-Hand Robotic System for Microsurgical Augmentation”, The International Journal of Robotics Research, 18(12):1201-1210 (1999).
www.cttc.co/technologies/maestro-non-robotic-dexterous-laproscopic-instrum-ent-writsproviding- seven-degrees, Maestro: Non-Robotic Dexterous Laproscopic Instrument With a Wrist Providing Seven Degrees of Freedom, accessed Nov. 12, 2015, 4 pages.
Yamashita, et al., “Development of Endoscopic Forceps Manipulator Using Multi-Slider Linkage Mechanisms”, The 1st Asian Symposium on Computer Aided Surgery-Robotic and Image-Guided Surgery, Ibaraki, Japan, 4 pages (2005).
Zeus, Robotic Surgical System, available at http://allaboutroboticsurgery.com/zeusrobot.html. (2017) 4 pages.
Non-Final Office Action mailed on Jan. 30, 2024, for U.S. Appl. No. 18/504,067, filed Nov. 7, 2023, 18 pages.
Invitation to pay additional fees for International Application No. PCT/EP2024/053361 dated Apr. 29, 2024, 22 pages.
International Search Report and Written Opinion mailed on Jun. 19, 2024, for International Application No. PCT/EP2024/053361, 31 pages.
Related Publications (1)
Number Date Country
20240268910 A1 Aug 2024 US
Divisions (1)
Number Date Country
Parent 18167779 Feb 2023 US
Child 18504087 US